Next-generation sequencing (NGS) technologies have revolutionised phylogenetic analysis by enabling the acquisition of genome-scale data. Phylogenetic inference reconstructs evolutionary relationships ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...
A new long-read DNA test improves rare disease diagnosis, replaces multiple existing tests, and could become the preferred ...
Hartwig and Ultima to continue implementation and validation of ppmSeq, the only decentralizable whole-genome solution commercially available today for monitoring of minimal residual disease (MRD) ...
20d
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the upcoming clinical availability of xH, a next-generation sequencing ...
In just a few decades, DNA sequencing technologies evolved from slow, manual processes to rapid, automated ones, making ...
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results